Morgellons and GMO’s

There is a conspiracy of selling out happening in America. Politics and personal interest it would seem determine government policies over and above health and safety issues. When President Obama appointed Michael Taylor in 2009 as senior adviser for the FDA, a fierce protest ensued from consumer groups and environmentalists. Why? Taylor used to be vice president for Monsanto, a multinational interested in marketing genetically modified (GM) food. It was during his term that GMO’s were approved in the US without undergoing tests to determine if they were safe for human consumption.

The danger of GMO’s

The question of whether or not genetically modified foods (GMO’s) are safe for human consumption is an ongoing debate that does not seem to see any resolution except in the arena of public opinion. Due to lack of labeling, Americans are still left at a loss as to whether or not what is on the table is genetically modified. This lack of information makes the avoiding and tracking of GM foods an exercise in futility. Below are just some of the food products popularly identified to be genetically modified:

The GMO link to strange disease

As early as 2008, we reported about a condition called Morgellon’s disease. The article went on to report the symptoms of the disease as follows: crawling, stinging, biting and crawling sensations; threads or black speck-like materials on or beneath the skin; granules, lesions. Some patients report fatigue, short term memory loss, mental confusion, joint pain and changes in vision. Furthermore, there have been reports of substantial morbidity and social dysfunction leading to a dip in work productivity, job loss, total disability, divorce, loss of child custody and home abandonment.

Prior to its reporting, the condition was dismissed as a hoax, but upon further investigation, the evidence pointed out that the disease was real and may be related to genetically modified food.

Despite this link being established, the CDC declared Morgellon’s disease of unknown origin. Worse, the medical community could not offer any information to the public regarding a cause for the symptoms.

When a research study was conducted on fiber samples taken from Morgellons patients, it was discovered that the fiber samples of all the patients looked remarkable similar. And yet, it did not seem to match any common environmental fiber. When the fiber was broken down, and it’s DNA extracted, it was discovered to belong to a fungus. Even more surprising was the finding that the fibers contained Agrobacterium, a genus gram-negative bacteria with the capacity of transforming plant, animal and even human cells.

Morgellon’s disease is not the only condition associated with genetically modified foods. A growing body of evidence has shown that it may cause allergies, immune reactions, liver problems, sterility and even death. Moreover, based on the only human feeding experiment conducted on genetically modified food, it was established that genetic material in genetically modified food product can transfer into the DNA of intestinal bacteria and still continue to thrive.

Heeding the warning

Time and again, the American Academy of Environmental Medicine (AAEM) has warned that GMOs pose a serious threat to health, and it is no accident that there can be a correlation between it and adverse health effects. In fact, the AAEM has advised doctors to tell their patients to avoid GMOs as the introduction of GMOs into the current food supply has correlated with an alarming rise in chronic diseases and food allergies.

This should come as no surprise. More than 30 years ago a food supplement called L-trytophan killed 100 people and affected 5,000 to 10,000 more. The cause was narrowed down to the genetic engineering process used in its production. If the symptoms had not had three simultaneous characteristics – namely, they were unique, acute and fast-acting – the disease could never have been identified.

If science could assure us with certainty that serious consequences do not wait for us at the end of the line, it might be to our best interest to let this opportunity pass. Progressive thinking in terms of profit is certainly not wrong. But to brush off precaution on the convenient argument that there is not enough evidence to prove that GM food is indeed harmful is sheer irresponsibility. It certainly is a lame excuse to offer in the event that GM foods are indeed proven to contain health hazards.

NutraSilver® is a Fast and Effective Morgellons Disease Treatment

What our customers tell us is when taking NutraSilver®, they heal and they heal quickly. We are not medical professionals; we are distributors trying to help people. We appreciate the dozens and dozens of testimonials from grateful

people who use NutraSilver® to treat their Morgellons disease and who after a few weeks have gone back to their previous lives without their non-healing lesions, brain-fog or most of the other debilitating symptoms. We sincerely hope you will try NutraSilver® and experience for yourself the amazing healing.

If you have Morgellons disease, you know this is not a skin disease. You know that Morgellons DISEASE is deep within your body and you know intuitively that the only way to treat Morgellons disease is from the inside. Pushing it out makes more sense than covering it up with skin creams and lotions, right?

Safe and Guaranteed To Work on Your Morgellons Symptoms

With our well-known and respected 60-day money-back guarantee, there is no risk to you when you buy NutraSilver.  Carefully tested in an FDA-certified lab, NutraSilver® demonstrated zero toxicity so NutraSilver® is safe to take.

NutraSilver® is proven safe to use. Argyria is a mostly a thing of the past and was the result of taking silver who’s particle size were far too large but mostly because the silver contained silver salts and silver chlorides and other impurities. NutraSilver® is 100% pure silver and scientifically engineered clustered distilled water. Nothing else. There has never been one case of argyria from the use of NutraSilver®. 

Order Now

Morgellons Disease Reversal

How long have you had Morgellons symptoms?

The answer really does not matter.  What matters is reversing them. We have found a way to eliminate your Morgellons symptoms in about 4 weeks using a natural mineral. What might you expect?

This is what you should expect;

week one;

• Your energy begins to return
• Your brain-fog begins to evaporate
• You can see better
• You can think clearer
• You see “debris’ leaving your body

week two;

• If you have lesions, they begin to harden around the edges
• The biting and scratching begins to subside
• Your movement in your scalp starts to go away
• You notice less fibers
• The black specs disappear

week three;

• Your lesions harden even further, some begin to fall off entirely
• The biting and scratching is almost gone
• Say good-bye to your depression
• Your mood improves

week four;

• Your lesions have mostly fallen off and do not return
• Your clarity of thought astounds you
• Nearly all of your Morgellons symptoms are gone
• You life is your own again
• You feel like ‘you’ again

Is this a pipe-dream, or is it real?

We have been helping Morgellons sufferers for over 5 years and those who stayed with the program and followed the instructions are mostly symptom-free now.  Once you obtain this level of relief, you seriously reduce how much NutraSilver you take to a minimum of about 15 drops, twice per day.

That’s it!  You are done!  Now it is time to return to your normal life without being accused by the medical profession of being delusional, without the feeling of hopelessness and without the debilitating brain-fog that stole your life.

Congratulations!  Your Morgellons nightmare is over!

NutraSilver, in FDA-certified independent lab test has shown to kill every pathogens we have tested both quickly and safely. WE are so sure that NutraSilver will reverse your Morgellons symptoms, we guarantee it for 60 days from the date we shipped it to you.  No questions asked.  Why doesn’t your Doctor of Pharmacist offer such a guarantee? You know the answer and so do we. End your Morgellons suffering now.  There is no need to suffer even one more day.

Full CDC Report on Morgellons Disease

Who participated?

Michele L. Pearson¹, Joseph V. Selby², Kenneth A. Katz³, Virginia Cantrell², Christopher R. Braden⁴, Monica E. Parise⁵, Christopher D. Paddock⁶, Michael R. Lewin-Smith⁷, Victor F. Kalasinsky⁸, Felicia C. Goldstein⁹, Allen W. Hightower⁵, Arthur Papier¹⁰, Brian Lewis¹¹, Sarita Motipara², Mark L. Eberhard^5*, for the Unexplained Dermopathy Study Team^¶

1 Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America, 2 Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America, 3 HIV, STD, and Hepatitis Branch, Health and Human Services Agency, County of San Diego, San Diego, California, United States of America, 4 Division of Food, Waterborne and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America, 5 Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America, 6 Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America, 7 Environmental Pathology, Joint Pathology Center, Silver Spring, Maryland, United States of America, 8 Office of Research & Development, United States Department of Veterans Affairs, Washington, District of Columbia, United States of America, 9 Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, United States of America, 10 Department of Dermatology, University of Rochester School of Medicine, Rochester, New York, United States of America, 11 Division of Health Studies, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, United States of America

Abstract

Background

Kaiser Hospital Oakland, California

Morgellons is a poorly characterized constellation of symptoms, with the primary manifestations involving the skin. We conducted an investigation of this unexplained dermopathy to characterize the clinical and epidemiologic features and explore potential etiologies.

Methods

A descriptive study was conducted among persons at least 13 years of age and enrolled in Kaiser Permanente Northern California (KPNC) during 2006–2008. A case was defined as the self-reported emergence of fibers or materials from the skin accompanied by skin lesions and/or disturbing skin sensations. We collected detailed epidemiologic data, performed clinical evaluations and geospatial analyses and analyzed materials collected from participants’ skin.

Results

We identified 115 case-patients. The prevalence was 3.65 (95% CI = 2.98, 4.40) cases per 100,000 enrollees. There was no clustering of cases within the 13-county KPNC catchment area (p = .113). Case-patients had a median age of 52 years (range: 17–93) and were primarily female (77%) and Caucasian (77%). Multi-system complaints were common; 70% reported chronic fatigue and 54% rated their overall health as fair or poor with mean Physical Component Scores and Mental Component Scores of 36.63 (SD = 12.9) and 35.45 (SD = 12.89), respectively. Cognitive deficits were detected in 59% of case-patients and 63% had evidence of clinically significant somatic complaints; 50% had drugs detected in hair samples and 78% reported exposure to solvents. Solar elastosis was the most common histopathologic abnormality (51% of biopsies); skin lesions were most consistent with arthropod bites or chronic excoriations. No parasites or mycobacteria were detected. Most materials collected from participants’ skin were composed of cellulose, likely of cotton origin.

Conclusions

This unexplained dermopathy was rare among this population of Northern California residents, but associated with significantly reduced health-related quality of life. No common underlying medical condition or infectious source was identified, similar to more commonly recognized conditions such as delusional infestation.

Citation: Pearson ML, Selby JV, Katz KA, Cantrell V, Braden CR, et al. (2012) Clinical, Epidemiologic, Histopathologic and Molecular Features of an Unexplained Dermopathy. PLoS ONE 7(1): e29908. doi:10.1371/journal.pone.0029908

Editor: Christophe Egles, Université de Technologie de Compiègne, France

Received: April 29, 2011; Accepted: December 7, 2011; Published: January 25, 2012

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Funding:Funding for this study was provided by the Centers for Disease Control (CDC) and Prevention.

'Delusional Baby'?

Epidemiologists from the CDC participated in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.

Competing interests: One or more of the authors are employed by a commercial, not-for-profit entity (Kaiser Permanente). This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.

* E-mail: mle1@cdc.gov

Additional membership of the Unexplained Dermopathy Study Team is provided in the Acknowledgments.

Introduction

Morgellons is a lay term that has been used to describe an unexplained constellation of symptoms, with the primary manifestations involving the skin. Persons who identify themselves as having the condition typically report poorly or non-healing skin lesions, excretion/emergence of fibers or solid material from the skin, and pruritus or other disturbing cutaneous sensations such as formication, stinging and biting, or a pins-and-needles sensation. These symptoms are usually described as being chronic and recurrent [1].

Persons who suffer from this unexplained dermopathy sometimes also report various non-cutaneous symptoms such as generalized fatigue, difficulty concentrating, short-term memory loss and depressed mood. Some report co-morbid conditions such as chronic fatigue syndrome, fibromyalgia, neurocognitive deficits, neurological conditions such as multiple sclerosis, and psychiatric disorders. Although no fatalities have been proven to have resulted directly from this condition, some reports suggest that persons with the condition have experienced substantial declines in quality of life, including social disruption and isolation, decreased work productivity or job loss, and total disability [2].

'Delusional Morgellons Lesions'?

This condition is not currently recognized as a distinct clinical disorder with established diagnostic criteria that are generally accepted by the medical community and many dermatologists consider the condition to be synonymous with delusional parasitosis (DP). To date, most of what is known about the condition is based on isolated case reports or anecdotal accounts. A range of potential infectious (e.g., Lyme disease, parasitic) and non-infectious causes has been postulated, but the etiology of this condition remains unknown and there have been no proven effective medical therapies.

Over the past few years, the Centers for Disease Control and Prevention (CDC) and several state and local health departments have received an increasing number of inquiries from the public and providers regarding this condition. In response, we conducted an investigation in Northern California where a possible cluster of illness was reported by local public health officials. We sought to better characterize the clinical and epidemiologic features of this condition, to estimate its prevalence in a defined population, and to generate hypotheses about causative or contributory factors. In this report, we present the findings.

Methods

Study Population

This study was conducted among enrollees of Kaiser Permanente of Northern California (KPNC) during July 2006 through June 2008. KPNC is an integrated, managed care consortium that has approximately 3.2 million enrollees, representing nearly 30% of the population in 13 Northern California counties. The membership is sociodemographically and culturally diverse, but highly representative of the general population [3].

Study Design and Eligibility Criteria

This descriptive case series study had three major components: a cross-sectional survey, clinical evaluations, and histopathologic studies. To be eligible for study enrollment, a KPNC member had to be ≥13 years of age

non-exsisting Morgellons lesions

and English-speaking. Participants provided written informed consent for the clinical examination, including photographic documentation of their skin (total body and lesion images) and collection of all clinical samples, including biopsies, blood, urine and fibers/materials. The study was reviewed and approved by Institutional Review Boards at CDC, KPNC, the Armed Forces Institute of Pathology (AFIP), and the University of Rochester.

Case definition

A case-patient was defined as any person who was a member of, and received care at, KPNC for any period between July 1, 2006 and June 30, 2008 (case-finding period) and reported fibers, threads, specks, dots, fuzzballs, granules or other forms of solid material coming out of his/her skin; AND one or both of the following:

• a skin lesion such as a rash, wound, ulcer, or nodule; OR
• a disturbing skin symptom such as pruritus, feeling that something is crawling on top of or under the skin, or stinging, biting, or a pins and needles sensation.

Case-finding

To identify cases, we first searched the electronic health records of KNPC enrollees to identify clinic visits with certain keywords (i.e, “Morgellons”, “fiber”, “thread”, “fuzzball”, “dots”, “specks”, “granules”, “delusion”) recorded

"clueless' Researcher

in the progress notes or with the ICD-9-CM code 300.29 (delusions, parasitosis), the code used at KPNC for patients with Morgellons. The search was limited to dermatology, psychiatry, infectious diseases, pediatric, and primary care clinic visits.

Next, study team members used pre-defined criteria to review the medical records of all persons identified by the electronic search to determine if they had suggestive signs and symptoms. Finally, persons who met medical records review criteria were screened by telephone by a member of the research team using a standardized tool to determine if they met the case definition; those who met the case definition were invited to enroll in the study.

Persons who were not captured by the electronic search but contacted KPNC research staff seeking study participation also were screened by telephone to determine if they met the case definition. If so, they were invited to enroll in the study.

Prevalence Estimates and Geospatial Analysis

To estimate the prevalence of cases, we used as our denominator the average monthly KPNC enrollment during July 2006–June 2008. We enumerated total, and age- and sex-specific monthly enrollment. Because the electronic health record (EHR) was being introduced during the case-finding period, we used only data from facilities in which the EHR was functioning (and therefore identifying potential cases) in each monthly denominator. Case-patients who self-identified were not included in the numerators of the rate estimates. Geospatial analysis was done to evaluate the possibility of geographic clustering of cases in KPNC’s 13-county catchment area.

Cross-sectional Survey

Persons who were study eligible were invited to complete a self-administered, Internet-based survey (or alternatively a telephone administered survey) to collect detailed epidemiologic data. Information collected at the survey included additional demographic data, household information, prior medical history, details regarding skin symptoms, pet ownership, travel history, tobacco, alcohol and illicit drug use history, and potential environmental exposures in the home or community. The SF-12 v2 Health Survey® (QualityMetrics) was used to assess measures of health-related quality of life, including self-perceived health status and well-being and Physical Component Scores (PCS) and Mental Component Scores (MCS). Mean PCS and MCS were compared with expected norms of 50 (standard deviation [SD] of 10) for the US population [4].

Clinical Evaluation

Additional inclusion criteria for the clinical examination were: age ≥18 years; self-reported active skin symptoms (consistent with the case definition) within the preceding 2 weeks, and current membership in KPNC. All components of the clinical evaluation were done at a Kaiser Permanente’s Division of Research in Oakland. Standardized data collection forms were used for all components of the examination.

Clinical examinations

How long have you been 'nuts'?

A medical history and a general physical examination were administered by an internist. A dermatologist administered a separate examination which included documentation of skin findings, collection of skin biopsies, and collection of fibers or other material present on the skin. Total body photographs were done by a medical photographer to document case-patients’ overall skin condition and the distribution of lesions.

Standardized criteria were used to categorize lesions and grade (normal, mild, moderate, severe) the extent of skin abnormalities. The number, location and types of lesions were recorded by body area. Additional comments were included, as appropriate, to record clinical impressions that were not captured adequately by the standardized form. Participants self-rated the severity of their skin symptoms within the 24 hours preceding examination, using a Likert scale.

Collection of Skin Samples and Foreign Material

Skin samples were obtained using a 4 mm punch biopsy. Biopsies, up to five per participant, were obtained from abnormal and clinically normal skin areas. An abnormal skin area was defined as one that had either

non-exsistant Morgellons fibers

abnormal appearance (to both participant and examiner) or abnormal sensation (although appearing normal). Two biopsies were possible per abnormal skin area (one for histopathologic analysis and, if clinically indicated, one for microbiologic culture); a single biopsy was obtained from normal skin. A dermatoscope was used to photograph each biopsy site before and after the procedure. Fibers or potential foreign material present on the participant’s skin were photographed, then collected and placed in a formalin-filled plastic container and sent for analysis. Only materials collected from participants’ skin by the dermatologist were sent for analysis. At study completion, an independent review of all dermatologic examination reports, dermatologic photographs and pathology reports was done by a second dermatologist.

Neurocognitive and Neuropsychiatric Testing

Participants were administered a battery of standardized neuropsychological tests. The Wechsler Test of Adult Reading (WTAR) was used to provide an estimate of intellectual functioning. Cognitive function was assessed using the: Stroop Color and Word Test; the Proverbs and Verbal Fluency measures of the Delis-Kaplan

What do you mean that you can't see my lesions?

Executive Function System™ (D-KEFS™); Ruff 2 & 7 Selective Attention Test; Brief Visuospatial Memory Test-Revised (BVMT-R™); Hopkins Verbal Learning Test-Revised™; and the Trail Making Test (TMT) Parts A & B. The PAI® (Personality Assessment Inventory™) was used to assess personality functioning and to screen for evidence of major psychiatric disorders [5]. All tests were administered in-person, scored and interpreted by trained neuropsychologists.

Raw scores on the cognitive tests and PAI scales were converted to T-scores using demographically adjusted normative data. T-scores ≤30 (corresponding to 2 Standard Deviations (SD) below the normative mean [50, SD = 10]) on the cognitive measures were considered clinically significant. T-scores >70 on the Personality Scales were considered clinically significant.

Laboratory Studies

Blood samples and serologic tests.

Too bad that there are no known blood-tests for Morgellons Disease

Blood was obtained for complete blood count with differential, erythrocyte sedimentation rate (ESR), serum glucose, serum ferritin, serum IgE, liver function tests, albumin, total protein, serum total calcium, phosphorus, serum blood urea nitrogen (BUN) and creatinine, Vitamin B12 and folate, serum Vitamin B1, antinuclear antibody (ANA), rheumatoid factor (RF), thyroid function tests, and C-reactive protein (CRP).

Serum samples were tested for hepatitis B surface antigen (HBsAg) and antibodies to hepatitis B core antigen (anti-HBc), hepatitis B surface antigen (anti-HBs), and hepatitis C (anti-HCV). Past or present HBV infection was defined as the presence of anti-HBc. Persons with test results positive for anti-HBs and negative for anti-HBc were considered to have vaccine-induced immunity.

At CDC, serum samples were tested for the presence of antibodies to Borrelia burgdorferi, Toxocara and Strongyloides. B. burgdorferi seroreactivity was determinedusing a polyvalent (IgM/IgG) enzyme immunoassay (EIA) (Vidas; BioMérieux Vitek, Hazelwood, MO) and separate IgM and IgG Western blot (WB) (Marblot; MarDx Diagnostics, Carlsbad, CA). Low-passage B. burgdorferi, strain B31, was used as the antigen source for both assays. B. burgdorferi seropositivity was defined based on the IgG WB as serum specimens were collected 130 days after illness onset [6]. Specimens with at least 5 of 10 IgG diagnostic bands by WB were considered positive, in accordance with the CDC-recommended criteria [6].

To detect Toxocara antibodies, a Toxocara EIA that detects both T. canis and T. cati infections was used. The assay utilizes T. canis excretory-secretory (TES) antigens from infective-stage larvae and antibodies are measured and reported as a titer. A positive Toxocara result was defined as a titer ≥1:32 [7].

Seropositivity to Strongyloides was determined using a quantitative ELISA which measures antibodies to a crude larval extract purified from infective third-stage larvae of S. stercoralis. A positive Strongyloides result was defined as a value ≥1:7 [8].

Non-blood samples and tests.

Urine was obtained for microscopy and, if pyuria or bacteriuria was detected, sent for culture. Because of the association between drug use and formication, participants’ hair samples were tested to determine the presence of amphetamines, barbiturates, benzodiazepines, cocaine, cannabinoids, methadone, opiates, phencyclidine and propoxyphene (HairConfirm, Craig Medical Distribution, Inc., Vista CA). Chest radiographs also were performed.

Swabs obtained from open skin lesions were sent to Quest Diagnostics® for microbiologic analysis, including

Morgellons is not bacterial, viral or fungal; I guess it does not exist?

gram stain, bacterial and fungal cultures. Viral cultures were performed if the lesions were clinically consistent with a viral etiology.

Histopathologic, immunohistochemical, molecular qnd chemical evaluation of biopsy specimens.

Skin biopsy samples were placed in 10% formalin and sent to CDC. 3 µm sections were prepared, stained with hematoxylin and eosin (H&E) and evaluated by a team of infectious diseases pathologists for histopathologic changes, using light microscopy and for exogenous material, using polarized light. Specimens showing inflammatory cell infiltrates on light microscopy were further evaluated on additional sections using special stains (i.e., Lillie-Twort, Warthin-Starry, and Grocott methenamine silver techniques) to detect bacteria or fungi and, if an infectious agent was identified, by immunohistochemical (IHC) stains, and/or PCR assays [9]–[13].

H&E-stained slides prepared at CDC were anonymized and sent to AFIP, along with two unstained, consecutive cuts from the same biopsy (one mounted on a carbon disc, the other on an aluminum coated slide) to maximize the probability of detection and analysis of fibers or material in the sections. At AFIP, H&E-stained sections were evaluated by light microscopy by two dermatopathologists who were blinded to the clinical diagnosis of the cases and under polarized light by a pathologist with experience in the evaluation of unidentified materials in tissue sections. Tissue sections containing unidentified material were further analyzed by scanning electron microscopy with energy dispersive X-ray analysis (SEM/EDXA) to determine the material’s elemental composition and by infrared spectroscopy (IR) to identify molecular characteristics [14], [15]. The measured infrared spectra were compared with those of authentic samples such as cotton gauze (for cellulose), and to spectra stored in a digital spectral library.

Molecular and Spectral Analysis of Fibers and Other Material.

Fibers or other materials collected from participants’ skin were analyzed at AFIP. Submitted materials were photographed, attached to aluminized slides by drying, crushing or by using conducting adhesive tabs (Polysciences Inc., Warrington, PA) and then analyzed by SEM/EDXA and IR [14], [15].

Statistical analysis

Continuous data were summarized using descriptive statistics, including mean, standard deviation, minimum, maximum, median and inter quartile range. Categorical data was summarized using frequency counts and percents; confidence limits around point estimates were determined, where indicated. Categorical variables were compared using chi-square tests. Census block data were analyzed using ArcGIS Geographic Information System software and SaTScan cluster analysis software to determine geospatial patterns and assess geographic clustering of the cases by place of residence.

Results

Case Finding and Characteristics, Prevalence Estimates and Geospatial Mapping

The summary of case-finding and study enrollment efforts are shown in Figure 1. A total of 115 KPNC enrollees met our case definition; 104 (90.4%) were identified by search of electronic health records, representing a prevalence of 3.65 (95% CI = 2.98, 4.40) per 100,000 enrollees. The rate was higher among females than males and highest amongst persons 45–64 years of age (Table 1). Eleven additional KPNC members who self-identified also met the case definition and eligibility criteria for study participation. There was no geospatial clustering of cases within the 13-county catchment area served by KPNC (p = .113) (Figure 2).

Figure 1. Summary of Case Finding and Study Enrollment Efforts, Unexplained Dermopathy, Calilfornia.

doi:10.1371/journal.pone.0029908.g001

Figure 2. Geospatial Mapping of UD Cases By Place of Residence, California.

doi:10.1371/journal.pone.0029908.g002

Table 1. Age-and Sex-specific Prevalence Rates of Unexplained Dermopathy, California, July 2006–June 2008.

doi:10.1371/journal.pone.0029908.t001

Case-patients had a median age of 55 years (range: 17–93); 89 (77.4%) were female. When screened for study eligibility, 81/115 (70.4%) case-patients identified the material emerging from their skin as “fibers” (alone or in combination with other materials); the remaining 34 (29.6%) identified the materials as other than fibers, including specks (59%), granules (56%), dots (50%), worms (35%), sand (32%), eggs (32%), fuzzballs (21%), and larvae (15%).

Cross-sectional Survey

"Debris' from Morgellons sufferer

A total of 70 (61%) case-patients completed the cross-sectional survey. Case-patients who completed the survey were more likely to be female (p = .04), but did not differ by age when compared with case-patients who did not complete the survey (data not shown).

The sociodemographic features of survey completers are shown in Table S1. The reported duration of symptoms ranged from 1.3 to 28.6 years (median: 3.7 years), with 69% participants reporting an illness duration of 2–5 years. The distribution of cases by reported year of illness onset is shown in Figure 3. Case-patients who reported “non-fibers” tended to report later illness onset (p = .057), but otherwise were similar to those who identified the material emerging from their skin as “fibers.”

Figure 3. Distribution of Case-patients by Self-reported year of Onset, California.

doi:10.1371/journal.pone.0029908.g003

Symptoms, Habits and Potential Exposures.

Case-patients’ symptoms are summarized in Table S2. There was no specific distribution to the skin symptoms, with 74% of case-patients stating that all areas of their body were affected. Half of case-patients described onset of skin symptoms as gradual. The reported sequence of skin symptom onset varied, with 57% of case-patients reporting disturbing skin sensations as the initial manifestation (followed either by skin lesions and/or solid material); 16% reported skin lesions as the initial manifestation; 10% the appearance of solid material as the initial manifestation; and 13% reported the triad of skin symptoms began simultaneously. Ten (14%) and seven (10%) case-patients, respectively, reported similar skin symptoms in a family member or friend.

No predominant temporal, diurnal or seasonal pattern to occurrence of skin symptoms or the emergence of material from the skin was reported, with 84% of respondents indicating that they had experienced skin symptoms “frequently” or “all the time” and 66% indicating that they noted fibers/solid material “anytime of the day.” Of the 14 (20%) who reported a seasonal occurrence of skin symptoms, 50% reported their symptoms as being worse during summer, 36% during spring, and 14% during winter.

Fibers and other material emerging from the skin were described as having a wide range of colors, with most (86%) being detected on skin areas with abnormal sensation; 73% reported having experienced the emergence of fibers or solid material from areas where there were no breaks in the skin.

Case-patients also reported a variety of non-skin symptoms involving multiple organ systems; non-skin symptoms reported by at least 50% of cases are shown (Table S2). Fatigue of ≥6 months duration and musculoskeletal complaints were among the most commonly reported, affecting 70% and 71% of case-patients, respectively.

When queried about habits and other potential exposures, some case-patients reported sharing personal items

Sorry, we can't find anything wrong with you

such as hairbrushes (18%), razors (13%), and towels (11%) or sharing a bed with another person (41%) or a pet (57%). Few case-patients reported using a hot tub (17%) or Jacuzzi (15%), residing in proximity to a land fill (3%), hazardous waste (3%) or industrial site (4%), or near live stock (3%) or orchards (1%) or travel in relation to symptom onset (20%). Most (78%) reported engaging, or having a household member who engaged, in hobbies or activities that involved the use of solvents (e.g., furniture stripper, paint thinner, turpentine, charcoal lighter fluid).

Case-patients reported using a wide range of topical and systemic over-the-counter, prescription and alternative therapies to alleviate their skin symptoms; no drug or treatment was consistently reported to be effective.

Health-related Quality of Life.

Over 50% of case-patients rated their overall health status as fair or poor, a proportion significantly higher than reported among California residents or nationally (Table 2). Case-patients’ PCS (mean = 36.63, SD = 12.9) and MCS (mean = 35.45, SD = 12.89) scores also were significantly lower than expected national norms (mean = 50).

Table 2. Prevalence of Fair or Poor Self-rated Health Among Case-patients Completing Web-based Survey, Unexplained Dermopathy, California.

doi:10.1371/journal.pone.0029908.t002

Clinical Evaluations

Forty-one case-patients received clinical evaluation; they did not differ in sociodemographics from those who completed the survey but did not receive clinical evaluation (data not shown). On general clinical examination, six case-patients had muscle tenderness, one had cervical spine tenderness, and one had a positive Romberg. None had fever or lymphadenopathy.

At the time of clinical evaluation, 60% of case-patients rated the severity of their skin symptoms as five or greater (10 = most severe); 15 (37%) and 25 (61%), respectively, reported having fiber/material currently present or emerging from their skin within the previous 24 hours.

Type, Distribution and Severity of Skin Lesions.

Clinical presentations varied substantially, including papules, scars, plaques, patches, macules, and one cyst. No case-patient had vesicles, bullae or burrows (suggestive of scabies). Many lesions were crusted, including some that were ulcerated or eroded. Some lesions and the surrounding area showed signs of inflammation (redness, warmth, tenderness).

Morgellons lesions before and after using NutraSilver

A median 17 lesions (range, 0–59) were documented per patient. The forearms (right, 83%; left, 71%), back (68%), chest (66%), face (66%) and lower legs (right, 63%; left, 66%) were the most commonly affected areas. Most arm lesions were on the posterior surface with sparing of the anterior surface. When back lesions were present, there was usually sparing of a dumbbell-shaped area in the center of the back. Clinically, the findings were most consistent with excoriations or chronic irritation, some with evidence of secondary infection. Representative skin findings are shown (Figure 4A–D).

Figure 4. Representative skin lesions detected on clinical examination.

A. Three erythematous scaly plaques with a fourth more proximal eroded and crusted plaque. B. Close-up of the eroded plaque in image 4A showing blue fibers. C. Excoriated erythematous papules suggestive of arthropod bites, dermatitis or possible excoriated folliculitis. D. Close-up of excoriated lesion in image 4C.

doi:10.1371/journal.pone.0029908.g004

Neurocognitive and Neuropsychiatric Assessments.

Of 41 case-patients who underwent clinical evaluation, 36 (88%) completed the full battery of neuropsychological tests. Case-patients had estimated IQ scores ranging from 84 (low average) to 126 (high average), with a mean score of 109.9 (SD = 12.2).

On cognitive testing, 59% (23/39) case-patients demonstrated impairment in at least one domain; attention (18%) and memory (16%) were the most common areas of impairment. On the PAI, 63% (25/40) of case-patients had clinically significant elevations (T>70) in scores for one or more of the clinical domains, with somatic concerns the most frequent (63%), followed by depression (11%) (Table S3). Of the 24 case-patients with scores suggesting clinically significant somatic complaints, 14 (39%) had evidence of co-existing depression, 10 (37%) evidence of other co-existing neuropsychiatric conditions, and 12 (50%) had T scores >87, suggesting severe impairment arising from the somatic complaints. Four (24%) had evidence of clinically significant past or present drug or alcohol use.

Laboratory Results

Few case-patients had abnormalities detected among the battery of blood tests; most were borderline abnormalities or abnormalities consistent with previously diagnosed conditions (e.g., diabetes, thyroid disease). Some case-patients had elevated markers suggestive of inflammation; five (12.5%) each had elevated RF or ESR, four (10%) elevated ANA, and three (7.5%) CRP.

Three (8%) case-patients had anti-HCV antibodies and five (12.5%, 2 borderline) anti-HBs antibodies. No case-patients had anti-HBc or HBsAg antibodies. One case-patient each had a positive or borderline EIA for B. burgdorferi, but none had a positive IgG WB. Three (8%) case-patients had positive serologies for Toxocara and three (8%) for Strongyloides.

At least one drug was detected in hair samples of 20/40 (50%) case-patients; these included amphetamines (3), barbiturates (1), benzodiazepines (8), cannabinoids (7), cocaine (2), opiates (8), and propoxyphene (1). All chest radiographs were interpreted as normal.

Histopathologic and Microbiologic Features of Skin Biopsies

Of 41 case-patients who received clinical evaluation, 31 (75%) were deemed to have lesions amenable to biopsy or to have material that was present on the skin for collection. Biopsies (n = 62) were distributed across the entire body surface; 37 were from lesions, 22 from clinically normal skin and three were from undocumented sites.

Histopathologic features of the biopsied skin lesions were varied and representative findings are shown (Figures 5 and 6). Solar elastosis was the most common histopathologic abnormality, present in 19 (51%) biopsied lesions. Fifteen (40%) biopsied skin lesions showed histopathologic evidence of excoriation or chronic irritation (lichen simplex chronicus or prurigo nodularis); six (16%) others had features consistent with an arthropod bite or drug allergy.

Figure 5. Representative histopathologic features of case-patient skin lesions.

A. Epidermal hyperplasia with compact orthokeratosis and hypergranulosis and perivascular inflammatory infiltrates in the dermis consistent with lichen simplex chronicus. B. Focal erosion with superficial ulceration and scale-crust consistent with excoriation. C. Mixed perivascular inflammatory cell infiltrates comprised of lymphocytes, neutrophils and eosinophils, suggestive of arthropod bite or drug reaction. D. Suppurative folliculitis comprised of eosinophils and neutrophils. Hematoxylin and eosin stain, original magnifications ×25 (A, B), ×100 (C), and ×50 (D).

doi:10.1371/journal.pone.0029908.g005

Figure 6. Superficial infectious processes identified in impetiginous skin lesions of case patients.

A. Superficial and deep perivascular dermatitis with epidermal hyperplasia and prominent scale-crust. A heavy growth of Stenotrophomonas maltophilia was obtained in culture of this site. B. Ulcerated skin with purulent exudates and serum-crust containing numerous colonies of coccoid bacteria (C) that stain intensely by using an immunohistochemical technique for Streptococcus pyogenes D and E. Purulent serum-crust from an impetiginous lesion, with abundant colonies of gram-positive coccoid bacteria (F). A heavy growth of Staphylococcus aureus was obtained in culture of this site. Hematoxylin and eosin stain (A, B, C, F), immunoalkaline phosphatase with naphthol fast-red and hematoxylin counterstain (D), and Lillie-Twort stain (F). Original magnifications ×12.5 (A), ×25 (B), ×50 (C), ×100 (D, E), and ×158 (F).

doi:10.1371/journal.pone.0029908.g006

Birefringent material was detected in 16 (43%) biopsied skin lesions. Most materials detected had the spectral characteristics of cellulose, compatible with cotton fibers. In all but two specimens, the birefringent material was located either in the superficial scale-crust, at the edge of or separate from the tissue, or on the biopsy surface and did not elicit a tissue reaction. Foreign-body-type giant cells were identified in two biopsies, one containing cellulose (most consistent with cotton fiber fragments), the other a silicon (Si)-containing material (likely silicates). Both of these biopsies had features suggestive of prior ulceration or trauma at the biopsy site.

By special stains, gram-positive bacteria or fungi were detected in 12 (11 participants) and eight (eight participants) specimens, respectively. For six of these specimens, IHC or PCR testing of the formalin-fixed tissues confirmed the bacteria as Streptococcus pyogenes (3), Staphylococcus aureus (2), or a Streptococcus sp. (1).

Culture swabs/specimens (n = 53) were obtained from open or purulent skin lesions of 28 case-patients. Organisms grew from the lesions of 15 case-patients; the histopathologic features of the culture-positive skin lesions were consistent with secondary infection (Figure 6). No skin lesions had detectable mycobacteria or parasites.

The 22 biopsies obtained from clinically normal sites were interpreted as histologically normal, except for solar elastosis (n = 5), sparse superficial perivascular inflammation (n = 5), chronic inflammation with rare eosinophils (n = 1), focal spongiosis, exocytosis and solar elastosis (n = 1) and a benign focal intradermal nevus. Five of these non-lesional biopsies contained cellulose fibers (resembling cotton), either adjacent to, or at the edge of, the biopsy; one had chronic perivascular inflammation and a birefringent material consistent with polyglycolic acid, a substance used in resorbable suture. None of the biopsies containing cellulose or polyglycolic acid had accompanying tissue reaction.

Analysis of Fibers or Materials From Non-biopsy Skin Sites

Twenty-three fiber or other material specimens were obtained from diverse intact skin sites in 12 case-patients. The materials were largely composed of protein (83%), likely superficial skin or cellulose consistent with cotton fibers (43%), some with evidence of dyes (Figures 7 A–B). Three samples contained other materials alone or in combination, including polyamide (probably nylon); cellulose nitrate containing bismuth (Bi) consistent with nail polish; and polyethylene (possible contaminant from specimen container lid).

Figure 7. Spectral characteristics of fibers/materials.

A. Photograph of formalin-fixed material with the IR spectral characteristics of cellulose consistent with a cotton fiber. B. Upper panel IR spectrum obtained from unidentified fiber, lower panel spectrum is a cellulose reference.

doi:10.1371/journal.pone.0029908.g007

Discussion

In this study, we collected detailed epidemiologic, clinical and laboratory data to better characterize the features of an unexplained dermopathy often referred to as Morgellons. Among this study population, this unexplained dermopathy was rare, predominately affecting middle-aged, Caucasian, women. Over 75% of our cases reported onset of their symptoms during or after 2002, but the epidemiologic importance of this is unclear as it also corresponds to the time when Internet postings related to this condition began to surface. We did not identify clustering of illness within the geographic area served by KPNC and from which cases were drawn.

Case-patients had a wide range of skin lesions, suggesting that the condition cannot be explained by a single, well-described inflammatory, infectious, or neoplastic disorder. A substantial proportion (40%) of biopsied lesions had histopathologic features compatible with the sequelae of chronic rubbing or excoriation, without evidence of an underlying etiology. The most common histopathologic abnormality was solar elastosis, a degeneration of dermal connective tissue and increased amounts of elastic tissue due to prolonged sun exposure. However, this finding might be expected among a population residing in California and does not necessarily suggest a causal relationship. Histopathologic examination of skin areas with normal appearance were essentially normal, arguing against systemic or subclinical skin abnormalities. Among the differential diagnoses for the skin presentations detected are neurotic excoriations [16], atopic dermatitis, brachioradial pruritis [17], [18], and arthropod bites.

Previous reports of this condition have described the material emerging from the skin being like fibers, hairs or filaments [1], [19], but we found a more heterogeneous description of materials emerging from the skin, with many case-patients describing materials other than fibers including specks, dots, granules, or worms. We found no difference in the sociodemographic, clinical, or histopathologic characteristics of case-patients who did and did not report fibers. The fibers and materials collected from case-patients’ skin were largely consistent with skin fragments or materials such as cotton and were either entrapped in purulent crust or scabs, suggesting the materials were from environmental sources (e.g., clothing) or possibly artifacts introduced at the time of specimen collection and processing.

We explored several possible etiologies and exposures. Our population had few clinical or laboratory signs of medical conditions that may be responsible for the symptoms, despite a wide range of accompanying multisystem complaints. We also did not find a pattern of clinical or epidemiologic abnormality that suggested any specific infectious etiology and, where data were available, the prevalence of specific parasitic infections in our population was no higher than that found in larger population-based studies [20]. We found evidence of drug use in 50% of participants. Formication can be a side affect drug use (prescription and illicit) and drug withdrawal, but the extent to which case-patients’ drug use contributed to, or was being used as a treatment for, the condition was not determined. The high prevalence of drug use also may represent some case-patients’ attempts to alleviate frustration or symptoms associated with the illness. Also, we found that over 75% of case-patients reported some exposure to solvents during hobbies. The prevalence of such exposures in the general population is unknown and we did not gather specific information regarding the types and duration of solvent exposures.

The prevalence of co-existing neuropsychiatric morbidity appeared to be high among our population based on measurements obtained by standardized screening instruments. Nearly 60% of case-patients had evidence of some cognitive impairment that could not be explained by deficits in IQ. Additionally, 63% of case-patients had clinically significant somatic complaints; nearly a third had somatic complaint scores that were elevated to levels rarely documented among other clinical populations but, when present, have been associated with chronic, multisystem complaints and incapacitating fatigue [5]. Lastly, we found functional impairment and disability (as measured by the SF-12) among the case-patients that exceeded that of the general population and comparable to that detected among persons who have serious medical illnesses and concurrent psychiatric disorders [21]–[23].

There are few studies of Morgellons in the medical literature with which to compare our study findings. In a report of 25 self-referred Morgellons patients, a minority (<1/3) had fibers detected at the time of examination and the most frequent dermatologic diagnosis was senile angiomas (72%); several patients had elevated cytokines (TNF-alpha, IL-6, IFN-gamma) [24]. We did not measure such markers in our study, but did find that a minority (15%) of case-patients had elevations in non-specific markers of inflammation, such as CRP and ESR. In another study of a convenience sample of Morgellons suffers from multiple states (46% from California), similar to our findings, those experiencing illness were predominantly Caucasian females and co-morbid conditions were common including a previous history of substance abuse (12%) and depression (29%) [25]. Neither study included biopsies or characterization of the materials obtained from patients’ skin.

Our study had a number of limitations. This study was limited to KPNC enrollees who had current or recent symptoms (<3 months) thereby limiting our ability to describe the full clinical course of illness and to generalize the findings. However, our focus on persons with active or recent illness likely increased our ability to detect abnormalities and recover fibers or other materials. Our cross-sectional study design and lack of a comparison group did not allow us to determine the temporal relationship between symptoms and potential exposures or co-morbidities or to assess risk factors for illness. As there is no established definition or diagnostic test for this condition, our case definition was based on self-reported symptoms and hence subject to reporting biases and potential misclassification of cases. Some case-patients did not complete all phases of the study, but those who completed all phases of the study were demographically similar to those who did not. Lastly, we limited enrollment to persons at least 13 years of age.

Despite these limitations, our study provides a number of insights. The study was done among a well-defined and highly representative population of California, allowing generation of the first prevalence estimates of the condition and allowing us to look systematically for illness clustering. We extensively characterized the skin lesions afflicting case-patients, including systematic examination of intact and involved skin. We also performed detailed spectral and molecular analyses of fibers and other materials that have been reported as the condition’s hallmark. Lastly, we assessed cognitive deficits, psychiatric co-morbidity and functional impairment among those affected.

To our knowledge, this represents the most comprehensive, and the first population-based, study of persons who have symptoms consistent with the unexplained dermopathy referred to as Morgellons. We were not able to conclude based on this study whether this unexplained dermopathy represents a new condition, as has been proposed by those who use the term Morgellons, or wider recognition of an existing condition such as delusional infestation, with which it shares a number of clinical and epidemiologic features [26]–[31]. We found little on biopsy that was treatable, suggesting that the diagnostic yield of skin biopsy, without other supporting clinical evidence, may be low. However, we did find among our study population co-existing conditions for which there are currently available therapies (drug use, somatization). These data should assist clinicians in tailoring their diagnostic and treatment approaches to patients who may be affected. In the absence of an established cause or treatment, patients with this unexplained dermopathy may benefit from receipt of standard therapies for co-existing medical conditions and/or those recommended for similar conditions such delusions infestation [31], [32].

Supporting Information

Table S1.

Sociodemographic Characteristics of Case-patients Completing Web Survey, Unexplained Dermopathy, California (N = 70).

(DOCX)

Table S2.

Skin and Non-Skin Symptoms Reported by Case-patients Completing Web Survey, Unexplained Dermopathy, California (N = 70).

(DOCX)

Table S3.

Results of Personality Assessment Inventory Among Case-patients Completing Clinical Evaluation (N = 36).

(DOCX)

Acknowledgments

The authors thank the study participants; Melissa Nelson, Deborah Burman, Joanna Truman, Karen Silva and Sharon Matthews at KNPC; Angela Austin, Binny, John Stamper, and Mark Lamias at CDC for assistance with database design and deployment; and the members of the CDC’s Unexplained Dermopathy Task Force.

The additional Unexplained Dermopathy Study Team Members: Patricia Adem, April Bolin, Lynn M. Blubaugh, Clare A. Dykewicz, Bruce F. Folck, James R. Hallman, Edmund T. Lonergan, George P. Lupton, Isabel T. McAuliffe, Florabel G. Mullick, Martin E. Schriefer, Wun-Ju Shieh, Patricia P. Wilkins, Sherif Zaki.

DISCLAIMER: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, Kaiser Permanente or the Armed Forces Institute of Pathology.

Author Contributions

Conceived and designed the experiments: M. Pearson JS CB KK MLE CP ML-S VK CD M. Parise BL. Performed the experiments: KK VC M. Pearson CP SZ ML-S VK LB PA GL MES W-JS PW JH GL SM EL IM FM. Analyzed the data: AB BF AWH AP FCG. Contributed reagents/materials/analysis tools: CP SZ ML-S VK LB GL MES W-JS PW IM JH SM. Wrote the paper: M. Pearson JS CP ML-S.

References

1. Savely VR, Leitao MM, Stricker RB (2006) The mystery of Morgellons disease: infection or delusion? Am J Clin Dermatol 7: 1–5. Find this article online
2. Morgellons Research Foundation website. Available: http://www.morgellons.org. Accessed 2011 July 25.
3. Gordon NP (2006) How does the adult Kaiser Permanent membership in Northern California compare with the larger community? Oakland, CA: Kaiser Permanente Division of Research website. Available: http://www.dor.kaiser.org/dor/mhsnet/pub​lic/kpnc_community.htm. Accessed 2010 December 5.
4. Ware JE, Sherbourne CD, Davies AR (1992) Developing and testing the MOS 20-item short-form health survey: A general population application. In: Stewart AL, Ware JE, editors. Measuring functioning and well-being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press. pp. 277–290.
5. Morey LC (1991) The Personality Assessment Inventory: Professional manual. Lutz, FL: Psychological Assessment Resources.
6. CDC (1995) Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR 44: 590–1. Find this article online
7. Glickman L, Schantz P, Dombroske R, Cypess R (1978) Evaluation of serodiagnostic tests for visceral larva migrans. Am J Trop Med Hyg 27: 492–8. Find this article online
8. McAuliffe I, Handali S, Lee Y, Noh J, Gleim E, et al. (2008) Optimization of and ELISA assay for the detection of S. stercoralis infection in humans. Abstract 532. 57th Annual Meeting of the American Society of Tropical Medicine and Hygiene. New Orleans, LA: ASTMH.
9. Guarner J, Packard MM, Nolte KB, Paddock CD, Shieh WJ, et al. (2007) Usefulness of immunohistochemical diagnosis of Streptococcus pneumoniae in formalin-fixed, paraffin-embedded specimens compared with culture and gram stain techniques. Am J Clin Pathol 127: 612–8. Find this article online
10. Guarner J, Sumner J, Paddock CD, Shieh WJ, Greer PW, et al. (2006) Diagnosis of invasive group A streptococcal infections by using immunohistochemical and molecular assays. Am J Clin Pathol 126: 148–155. Find this article online
11. Murdoch DR, Anderson TP, Beynon KA, Chua A, Fleming AM, et al. (2003) Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia. J Clin Microbiol 41: 63–6. Find this article online
12. Imrit K, Goldfischer M, Wang J, Green J, Levine J, et al. (2006) Identification of bacteria in formalin-fixed, paraffin-embedded heart valve tissue via 16S rRNA gene nucleotide sequencing. J Clin Microbiol 44: 2609–11. Find this article online
13. Thomas LC, Gidding HF, Ginn AN, Olma T, Iredell J (2007) Development of a real-time Staphylococcus aureus and MRSA (SAM-) PCR for routine blood culture. J Microbiol Methods 68: 296–302. Find this article online
14. Murakata LA, Lewin-Smith MR, Specht CS, Kalasinsky VF, McEvoy PL, et al. (2006) Characterization of acrylic polyamide plastic embolization particles in vivo and in human tissue sections by light microscopy, infrared microscopy and scanning electron microscopy with energy dispersive x-ray analysis. Mod Pathol 19: 922–30. Find this article online
15. Ganesan S, Felo J, Saldana M, Kalasinsky VF, Lewin-Smith MR, et al. (2003) Embolized crospovidone (poly[N-vinyl-2-pyrrolidone]) in the lungs of intravenous drug users. Mod Pathol 16: 286–92. Find this article online
16. Koblenzer CS (1996) Neurotic excoriations and dermatitis artefacta. Dermatol Clin Jul 14(3): 447–55. Find this article online
17. Lane JE, McKenzie JT, Spiegel J (2008) Brachioradial pruritus: a case report and review of the literature. Cutis January 81(1): 37–40. Find this article online
18. Veien NK, Hattel T, Laurberg G, Spaun E (2001) Brachioradial pruritus. J Am Acad Dermatol 44(4): 704–5. Find this article online
19. Kellett C (1935) Sir Thomas Browne and the Disease called the Morgellons. Annals of Medical History 7: 467–79. Find this article online
20. Jones JL, Kruszon-Moran D, Won K, Wilson M, Schantz PM (2008) Toxoplasma gondii and Toxocara spp. Co-infection. Am J Trop Med Hyg 78(1): 35–39. Find this article online
21. Centers for Disease Control and Prevention (CDC) (2008) Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
22. Stewart AL, Greenfield S, Hays SD, Wells KB, Rogers WH, et al. (1989) Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study. JAMA 262: 907–13. Find this article online
23. Wells K, Stewart A, Hays R, Burnam M, Rogers W, et al. (1989) The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 262: 914–19. Find this article online
24. Harvey WT, Bransfield RC, Mercer DE, Wright AJ, Ricchi RM, et al. (2009) Morgellons disease, illuminating and undefined illness: a case series. J Med Case Reports 3: 8243. Find this article online
25. Savely VR, Stricker RB (2010) Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology. Clin Cosmet and Investig Dermatol 3: 67–78. Find this article online
26. Robles DT, Romm S, Combs H, Olson J, Kirby P (2008) Delusional disorders in dermatology: a brief review. Dematol Online J 14(6): 2. Find this article online
27. Trabert W (1995) 100 years of delusional parasitosis. Meta-analysis of 1233 case reports. Psychopathology 28: 238–46. Find this article online
28. Wykoff RF (1987) Delusions of parasitosis: a review. Review of Infectious Disease 9: 433–37. Find this article online
29. Hinkle NC (2011) Ekbom Syndrome: A Delusional Condition of “Bugs in the Skin”. Curr Psychiatry Rep. DOI 10.1007/s11920-011-0188-0; posted 23 February 2011. Find this article online
30. Hylwa SA, Bury JE, Davis M, Pittelkow M, Bostwick JM (2011) Delusional Infestation, Including Delusions of Parasitosis: Results of Histologic Examination of Skin Biopsy and Patient-Provided Skin Specimens. Arch Dermatol 147(9): 1041–1045. Find this article online
31. Freudenmann RW, Lepping P (2009) Delusional Infestation. Clin Microbiol Rev 690–732. Find this article online
32. Accordino RE, Engler D, Ginsburg IH, Koo J (2008) Morgellons disease? Dermatol Ther 211(1): 8–12. Find this article online

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution License.

• Ambra 2.0
• Managed Colocation provided by Internet Systems Consortium.

Morgellons Attached by NutraSilver; My Daily Accounting

NutraSilver & Me

An Old Lady’s View of Life Today

The following is an actual journal of an elderly woman with Morgellons Disease.  Over the years, it had crippled her to the point that she literally could not walk or function. Her body was covered with open, weeping sores that seemed to never heal. We provided NutraSilver to her free in exchange for her journal and we are proud to share it with you…

If you have Morgellons, much of this will really sound familiar.

Saturday, June 13, 2009 2:56:55 PM

Well, I have finished my round of Nutrasilver. Two weeks and I have to say I do feel better. Here is a copy of the notes I made as I have progressed.

I started the NutraSilver May 27 -

I started with the 30 drops the enclosed flier recommended.  Within minutes I felt a crawling sensation on my scalp. I could feel the liquid in my stomach. I began to feel extra tired and laid down for a few minutes.

I had experienced leg pain for months

By the second dose the leg pain subsided. After the dose I went to bed. I woke up alert and clear headed for the first time in years,

On the 28th I took my 3rd dose

I could feel that my legs were better already. I could walk normally for the first time in weeks. I went out and worked in my garden for a couple of hours; unheard of in my world.  I upped the amount to 40 drops in the afternoon of the 28th.  I could feel the protein from the celiac move through my body

I’ve been in pain for so long from the celiac I didn’t notice side effects from the Nutrasilver killing off any pathogens.

On the 29th – today I upped the amount to 50 drops

I did feel tired and napped. The protein ( I call it poison ) had moved from my legs up through my body and ended up in my left arm. I couldn’t lift any thing today.  But my legs did not hurt and I did some one handed gardening this after noon.

I napped again after gardening. The poison moved into my upper left arm and shoulders.  I have noticed that the sores caused by the celiac have been draining more the past couple of days also.

To me , just being able to walk is worth the effort

May 30th 2009 -

I woke up today with no pain . For the first time in years. really years! I feel fine ! I start taking 60 drops this afternoon.

May 31st -

I can feel the poison moving around my body more these days. It feels like it is fighting back against the Nutrasilver. My stomach growled for the first time in years . Simple thing others excuse themselves for, has become an event for me !

I had the numbing feeling in my legs last night but this morning it’s moved around again.

The pain I was having has subsided, I can walk, stand and getup pain free

The poison has moved out of my upper arm into my shoulders and neck. My sores have been draining more too. It will be interesting to see if they heal.  Well, I washed the dog , planted more in my garden and put food on for dinner and it’s only 1:30 in the afternoon! Although I do get sleepy and need a nap, I still can do more now than in years.

Wow, I hope this continues!

June 1st.

Got up today leg pain is still gone, hurray!  I’m still quite tired but the body pain has lowered substantially .

I’m at 60 drops and will stay here for a few days – I believe my being tired is from the poisons in my body being killed off .

On with the test!

June 2nd

Leg pain still gone ! Yippee ! The stronger solution is making me slightly sick to my stomach today. Last night my left hand turned red and the sore on my wrist itched like mad all evening.

The poison is really moving !

The sores on my head , first fill and then drain then fill again. But, I have hope this stuff will leave my body . My

Healed Morgellons lesions

knees today seem to be the target . Will continue with the Nutrasilver.

June 3rd

Same as last few days – still tired.

June 4th

Went to bed at three am this morning and still up at 8:30, Feel fine , the poison has been moving around my body faster and faster. The sore on my wrist is still bright red but the scab is small compared to others I have had. I’ll feel much better when it goes away.

The poison seems to be trying to find a way out of my body.

My legs are much better than they have been in months – but I can feel the poison in my bones , sometimes in my forearms sometimes in my lower legs. But, compared to before I can stand this amount of pain and actually do things in my everyday life.

I can hug my grand daughters and not wince from the pain of their touch. So yes I do conclude that this product is helping me.

June 5th – 8th

Went away for the weekend – staying in a motor home I found I could climb the steps without pain ! That’s something I haven’t done in years ! Tuesday is suppose to be my last day of the 2 week trail period .

I’m concerned that the poison in my body is still not gone although the pain has decreased .

June 9th

Today is suppose to be my last day. I’m afraid that the the pain will return – I’ll just have to go off and see what happens . The “poison” moved into my hands today – I did little but play on the computer as I couldn’t hold much. By late afternoon it moved into my left shin – made it hard to walk all evening .

Attended a lodge meeting and then back home. By midnight the pain finally moved away.

June 10th

Woke up pain free this morning !

I’ll take a week and see what changes now without the Nutrasilver.

June 11th

Sores are draining on my head this morning . If nothing else this has made the poison rush through my body. I vision it like an alien trying to escape any way it can. The sores seem to drain faster and heal faster now. The pain in my legs is still minimal and I am pleased with that.

June 12th

Well today all the sores on my head are draining. I don’t know if this is because of the Nutrasilver or what , but I

Morgellons lesions before and after using NutraSilver

find it quite strange. I have soft spots under my scalp and once the poison works its way through my skin it drains . Yuck , but maybe this is the only way to get it out of my body .

My physical pain is at a much lower level than before. I can bear it most of the time. And I’m not quite so touchy as I have been in the past because of the poison traveling through my tissue.

Here it is June 13th and the pain is still at a lower level that it has been in years !

Next Tuesday I will start a one week round of the Nutrasilver and see if that does any more good. The sores have been draining constantly and I figure , what can that hurt. If the Nutrasilver helps with just that , it will be a miracle !

I’ll keep you posted .

• NutraSilver will end your Morgellons suffering,usually in about 4 weeks

• You get our well respected 60-day money-back guarantee; we take the risk and you heal quickly

• Join thousands of Morgellons sufferers who have returned to normal lives without Morgellons

Free Morgellons Telephone Consultations

If you wish to discuss how you can get your life back without Morgellons, call our toll-free number and our experienced (5+ years working directly with Morgellons victims) counselors will help you through this nightmare.  We have seen thousands of Morgellons victims recover.  It is your turn now, so pick up your telephone and call this number now or order online.

888-240-2326 Option #2 PST

CDC Morgellons Report; Read the Real Truth Here

CDC Report Failure

Despite having spent four years and $600,000, and using the world’s largest forensic database, the premier health agency reports it is unable to identify the source of the fibers emanating from those suffering with Morgellons.

The CDC provided more information in its press releases hyping the study than it did in the 300-word study published last week

That’s right; after 4 years and $600,000, all we get is 300 words. For you taxpayers, that’s a whopping $2,000 for EACH WORD!  Its Unexplained Dermopathy webpage goes beyond what was reported in the actual study, saying there is “no evidence of an environmental link,” and promised to do no further studies. How convenient. 

The CDC sent the cellulose and unnatural fibers to the , reports the Associated Press.  AFIP has been collecting fiber samples and other forensic material for 150 years. Its 2011 budget was $65 million. Surely, if these novel fibers are natural or lab-created, the AFIP would know. Apparently not. They were unable to discover the cause so they simply say they will never do any further studies! And to think that we, the taxpayers, paid for this?

What is the CDC hiding about Morgellons?

What the CDC didn’t say in the public report is that;

1. Those fibers are alive and motile
2. They grow and reproduce, and have been shown to do so in a petri dish using certain visible light frequencies
3. If delusions are creating them, that would be a first in human evolution
   

   Cliff Carnicom

Research conducted by Cliff Carnicom, a well-known and respected independent scientific researcher, indicates that the still-unidentified fibers seen in Morgellons patients are the same as those collected after an aerial spray of chemtrails.

After being cultured for five days, the fibers produced a sheen across the wine medium, right before explosively reproducing hundreds of new fibers in a 24-hour period.  He later explored how these nanoworms feed on the iron in human blood, explaining that, “changes in iron and the utilization of iron in a pathogenic sense are at the heart of the Morgellons issue.”

An arduous course of research led Carnicom to conclude that the nanoworms present in Morgellons patients represent an entirely new life form, and one that was engineered using features from each of the three Domains of life;

• Bacteria
• Archaea
• Eukarya

To bolster his argument, he refers to a Feb. 2010 disclosure by the Defense Advanced Research Projects Agency (DARPA) “to develop immortal ‘synthetic organisms’, as outlined in the unclassified version of the 2011 budget,” citing Wired.com:

As part of its budget for the next year, Darpa is investing $6 million into a project called BioDesign, with the goal of eliminating ‘the randomness of natural evolutionary advancement.’

“The project comes as Darpa also plans to throw $20 million into a new synthetic biology program, and $7.5 million into ‘increasing by several decades the speed with which we sequence, analyze and functionally edit cellular genomes.”

If these unidentified fibers are some sort of top-secret nanotech military weapon, that would explain why no answer and no help will come from the CDC or the military.

We do know that back in 2006, the National Institutes of Health (NIH) listed Morgellons as “a genetically caused disease, due to the presence of three copies of a chromosome rather than the normal two (known as trisomy). This was found at the 5S rRNA genes located on chromosome 1, in the q42.11 to q42.12 region, according to the following screen capture by Jan Smith, who explains that a year later NIH deleted the webpage.  I wonder why, don’t you?

We are being sprayed; just look up now and then and you will see for yourself

Several people agree with Carnicom that these living fibers are being sprayed on us via the vociferously denied

chemtrail program.  Morgellons patient Kandy Griffin, president of Morgellons Research Group, puts it right out there:

Morgellons is not a disease. It is a process. It is a form of forced/directed evolution of the human genome. It is the fetal stage of trans-humanism, and it is upon us.

“This stealth project is being carried out with the use of the daily chemtrail operations, which are happening globally.  There is no escape.  The chemtrail operations are terraforming the earth and everything on it, including you.”

There is hope and relief now

In the last section of Carnicom’s Thesis, he suggests several mitigation strategies that would apply equally to those who develop Morgellons and those who don’t, but who are likely assimilating rather than rejecting these bioengineered life forms.

Morgellons symptoms have been eradicated in thousands of sufferers for the past 5 years by a natural mineral that drives this ailment out of the human body from the inside.  Although not a cure, thousands of Morgellons sufferers have found relief by eliminating their symptoms allowing them to return to a normal life. Taken orally, this natural mineral has no toxicity and is lethal to harmful bacteria, fungus and viruses.  FDA-certified lab reports suggest that this natural mineral kills pathogens quickly and safely.

Morgellons lesions; before and after treatment

If you have Morgellons, there is a way to regain your life without the debilitating effects of Morgellons. Follow this link to find out more.

Morgellons Sufferers Respond Strongly to CDC Report

These quotes are from LymeBusters

 

Thanks for nothing, CDC!

Can’t say that this comes as a surprise, but it is still sickening. The observation that patients were depressed??? Would they be depressed if this was happening to them? Western medicine as practiced in the 21st century. Doesn’t get much scarier than this. I am so fed up that I can’t even talk any more.

Luckily I am in a place where most of my outward symptoms are controlled and I function pretty well, but I feel terrible for the folks who are still experiencing the onset and have no
where to go within the medical community to get any sort of help.

Guess these idiots never heard of Randy Wymore and the OSU study?

I knew in my heart… as well as many other morgellons sufferers have that your final report would be Godless, shameful, and so very disappointing. I tried to have faith in our government… I tried to hope for an honest

the CDC says Morgellons is "All in your head"

outcome of your study of Morgellons. But now I know how disgusting our government has truly become. You hide the truths by hurting the hearts of those who suffer from your attacks on us via chemtrails, GMO foods and the like. I’m so very sickened by the greed, the lack of compassion, and as I said, the lack of truth. But it’s my heart that’s been numbed by what you’ve accomplished in destroying even more lives with this so-called study. You must truly be ashamed of yourselves… I know I’m ashamed of you all. You’ve just destroyed so many people who’ve been holding on by a thread waiting for the answers to stop their suffering. How could you… how could you be so very heartless? I will continue to hope one of you who must know the answer but are being held to secrecy over the cause of this nightmare to step up to the plate one day. Maybe you will the day you or one of your loved ones is hit by the Morgellons delusion… a delusion I might add that has been filmed by thousands of people around the world. How can that be? Because… morgellons is as far from being a delusion as you are from being truthful, compassionate, and strong. So very disappointed in you all… but believe you me, our fight doesn’t stop here. For all who suffer… my heart is with you today.

_______________________________________________

The newspaper today here in Vegas (The Review Journal)
said:

“The study cost nearly $600,000.00. It’s long awaited results, released Wed, conclude that Morgellons exists only in the patients’ minds.”

End of quote.

_______________________________________________

You may not want to watch, because it’s really something that does add fuel to the fire.

I know these Morgelloons people are really sick.. I just can't help them because the CDC says Morgellons does not exist

 

I could chew heads off with my front teeth right about now, and feel WONDERFUL and thrilled doing it.

I’m venting, because ….we know, we know WE KNOW the TRUTH.

I wonder how many poor souls spent their time and money at this “supposed doctors office” in NY.

I am that fed up I can not talk anymore either. Sorry guys, that was another reason for the music.

12 hours sleep and I feel like I’ve been hit by a truck. The sleep walking is worse than ever. Tony came home from work to find that I’d been painting butter all over the kitchen.

Couldn’t get anymore frightening for me. Oh and that thing on my bum? My sister is a Nurse confirmed for me it looks like a boil. Well it really really hurts and I hope the drawing agent has worked overnight.

Well, there you have it.

Absolutely idiotic & shameful but considering it comes from the Centers for Disease Creation I am hardly surprised. They are under the authority of the military and since the military has obviously been involved in spreading Morgellons through chemtrails (Morgellons pathogens have been found in the chemtrails fallout encased in some type of artificial lattice) one can hardly expect involved government agencies to rat themselves out or take steps to expose what is really going on.

_______________________________________________

They don’t f—ing want us to know what the f–k is going on! Even worse the taxes we pay support this BS! We the taxpayers are funding this!!

I guess the CDC didn’t feel the need to look into the findings of researchers like Clifford Carnicom, Randy Wymore, Jan Smith & Hildegarde Stanninger who have respectively discovered that Morgellons causes pathological changes in the blood observable with a microscope. The fibers coming from Morgellons victims are unique and something that cannot be identified with previously known fibers or man-made fibers, that self replicating nano technology is involved and tiny nano tech robots have been repeatedly removed from various Morg sufferers and that there is excessive amounts of silicon in the bodies of Morg sufferers.

How does the CDC explain these pathologies that are consistently found in the bodies of those suffering from Morgellons?

Well this isn’t the first time the CDC has supported fraudulent science …the infamous Yale report on Lyme Disease is another shameful example.

I am made as hell and I’m not going to take it any more…

You can fight back; there is a way out, regardless of the CDC or the Medical Community might say. We have been assisting Morgellons sufferers for over 5 years to rid themselves of this debilitating and life-stealing disease. It is time to pick up the phone and finally find your way out of the Morgellons forest.  We can help; thousands of Morgellons sufferers have found relief and so can you.  It is time to end your Morgellons suffering. Call now for you free Morgellons consultation.

888-240-2326 option #2 PST

CDC Says Morgellons is Not Infectious [the only fact in the report]

Download Complimentary Source PDF By Crystal Phend, Senior Staff Writer, MedPage Today
Published: January 25, 2012

Reviewed by Zalman S. Agus, MD; Emeritus Professor
University of Pennsylvania School of Medicine and Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner

Action Points

Centers for Disease Control

Morgellons is a lay term for an unexplained chronic, recurrent dermopathy. It is characterized by poorly healing skin lesions associated with pruritus and other disturbing cutaneous sensations.

This study found no evidence of an underlying medical condition or infectious source for this rare condition.

A mysterious condition in which cloth fibers or other materials are reported to emerge from the skin doesn’t appear to be infectious, a CDC team said after studying a possible cluster of cases in northern California.

A wide range of tests turned up no single bacteria, mycobacteria, virus, or parasitic explanation for what is being called Morgellons, according to Mark L. Eberhard, of the CDC in Atlanta, and colleagues.

No environmental cause was found either, although neuropsychiatric problems, solvent exposure, and drug use were common among cases, the group reported in the January issue of PLoS One.

“In the absence of an established cause or treatment, patients with this unexplained dermopathy may benefit from receipt of standard therapies for coexisting medical conditions and/or those recommended for similar conditions, such [as] delusional infestation,” they wrote.

Patients with this rare skin problem report fibers or solid materials emerging from poorly healing wounds that

Delusional, non-existant fibers

itch or have other disturbing sensations, like crawling insects, stinging and biting, or pins-and-needles.

But when the researchers biopsied lesions in patients reporting these symptoms, the materials they found — mostly cotton fibers or skin fragments — appeared to have been introduced into scabs created by chronic scratching or irritation, rather than erupting from the skin.

These findings suggested “the materials were from environmental sources (e.g., clothing) or possibly artifacts introduced at the time of specimen collection and processing,” Eberhard’s group wrote.

The group’s Unexplained Dermopathy Study Team investigated a group of cases reported by public health officials in the San Francisco Bay Area, using the Kaiser Permanente of Northern California databases, which cover about 30% of the population in those counties.

Chart review turned up 115 patients at least 13 years old with Morgellons symptoms, for a prevalence of 3.65 cases per 100,000 enrollees in the managed care organization.

Delusional lesions

“Over 75% of our cases reported onset of their symptoms during or after 2002, but the epidemiologic importance of this is unclear as it also corresponds to the time when Internet postings related to this condition began to surface,” the investigators noted in the paper.

The cases didn’t meet criteria for clustering, but some similarities were seen in that 77% of the cases were Caucasian women.

Other common characteristics were multisystem complaints, with 70% reporting chronic fatigue and 54% reporting their overall health as poor or fair.

Neuropsychiatric problems also were common, with 59% having cognitive deficits that could not be explained by low IQ and 63% having clinically significant depression or other somatic complaints.

Testing turned up drugs in hair samples in 50%.

Most of the cases (78%) reported that they or someone in the household used solvents, such as paint thinner or charcoal lighter fluid, for hobbies or other activities.

The lesions themselves showed a wide variety of presentations, from papules and scars to plaques, patches,

More delusional lesions

and even one cyst. Many were crusted; some were inflamed.

Forearms, back, chest, face, and lower legs were most commonly affected, with a median of 17 lesions per patient.

These lesions were “most consistent with arthropod bites or chronic excoriations,” the researchers pointed out.

Some tested positive for bacteria, but no parasites or mycobacteria were detected.

“We were not able to conclude based on this study whether this unexplained dermopathy represents a new condition, as has been proposed by those who use the term Morgellons, or wider recognition of an existing condition such as delusional infestation, with which it shares a number of clinical and epidemiologic features,” the group concluded.

Delusional expendatures for medicines that don't help

Patients reported using many different over-the-counter, prescription, and alternative therapies in an attempt to alleviate symptoms, with nothing consistently reported effective.

Indeed, the biopsies turned up little that was treatable, the researchers noted.

Thus, skin biopsy may not be very useful without other supporting clinical evidence, although treating coexisting problems, like drug abuse and somatic symptoms, with currently available therapies might be one avenue to help these patients, they suggested.

The authors noted that the study was limited by the fact that case reports included only individuals with current or recent symptoms and used self-reported symptoms for definition, and by the fact that the investigators couldn’t examine risk factors or temporal relationships with exposures, comorbidities, and symptoms.

The study was funded by the CDC [and the US Army]

Some of the researchers were employed by the CDC and some by Kaiser Permanente.

Primary source: PLoS One
Source reference:
Pearson ML, et al “Clinical, epidemiologic, histopathologic and molecular features of an unexplained dermopathy”

This Bloggers Comments

Hundreds of thousands of Morgellons suffers who have never met or spoken with each other share the same delusions? Many have no access to the Internet, so they did not contract this delusional disease online.

There are newborn infants with Morgellons.  Are they delusional?

When Morgellons sufferers use NutraSilver and follow the instructions, they all heal.  How can anyone heal from a delusional disease?

How does the CDC explain the fact that Morgellons sufferers that use NutraSilver eliminate their “brain fog”, chronic fatigue and depression in about 2 weeks?

More Questions and No Answers From the CDC Report

The only truth we can find in the CDC report is that Morgellons is not infectious [contagious].

We have answers for you that really produce reduction in Morgellons symptoms.  NutraSilver is a simple natural mineral when taken orally, eliminates Morgellons symptoms in 4 weeks or less. If Morgellons is delusional, how can this be? The placebo effect on thousands of Morgellons sufferers?  I don’t think so and neither do you. Give us a call and we will be happy to speak with you about how you can eliminate your delusional, ha, ha, Morgellons symptoms safely and inexpensively. Don’t suffer another day; pick up the phone right now and begin your journey back to being who you really are.

888-240-2326 option #2 PST

CDC Report On Morgellons; Does it Really Matter to Those Who Suffer?

Absolutely! Or Not….

For those Morgellons sufferers who believed that our government would help them when no one else would, their

Does this lesion look delusional to you?

hopes are completely dashed by this report.

For those who already knew that the CDC, who took 5+ YEARS to study a paltry 115 people, finally came out with their conclusion that Morgellons is a delusionary condition and that there is no medical evidence to support its existence of Morgellons, were not surprised in the least. They have gone to MD’s and Dermitoligists for years and have been told the same thing.

And the News Media Says….

Most news stories about the CDC report on Morgellons is simply a copy of one story, most news agencies simply tell the CDC side of the story.  Such is not the case with ABC, who broadcast a fair and balanced humanized version of the impact of this report. You can see the ABC News report here.

My Heart Goes Out to Morgellons Sufferers Worldwide

I have been helping and supporting Morgellons sufferers for over 5 years and believe me when I say that nearly all of the conversations I have had with Morgellons sufferers are with real people who are NOT delusional.  They speak clearly, they articulate their words and sentences and are genuinely suffering horribly. many are highly educated people, some are even MD’s. A particular MD called me last week from San Diego with a single lesion covering his entire forehead; I know because he sent a picture of himself.  when he went to the local Emergency Room and identified himself as a medical doctor, he was treated the same way most Morgellons sufferers are treated by ER’s.  He was charged for the visit and promptly escorted out of the ER by security officers. Shameful, simply shameful.

Morgellons Sufferers Are Human Beings

They really are.  They have had their lives stolen from them by this bizarre disease that no one seems to know anything about. Many have lost their jobs, their homes, their spouses and their dignity. And what do they get when they request help from the medical community?  Disdain, disrespect and apathy. I have seen lives destroyed with absolutely no hope whatsoever.  And now the CDC informs them that “it is all in their heads.”  Imagine how you might feel under these circumstances.

Morgellons Suffers; What’s Next For You?

How dare you tell me that I am delusional; I am suffering horribly...

You keep up the good fight, you don’t give up and you don’t believe the CDC report because you are not delusional; you have an infection and you need help and love and support from friends and family.  Don’t expect any of this from the medical community. Until many more thousands of Morgellons sufferers arrive, there is simply no money for any real research.  Oh, there are pockets of under-funded scientists who know through real evidence that Morgellons disease is real and they will continue to do what they can to identify what this ailment really is. Until then, there simply is no financial incentive for the medical community to do anything except take your money and tell you that you have Delusions Of Parasitosis (DOP).

We Can Help You Find Your Way Out of This Nightmare

60-day money-back guarantee

Thousands of Morgellons suffers have become symptom-free using a natural mineral called NutraSilver. We invite you to explore our well respected 60-day money-back guarantee.

Free Morgellons Telephone Consultations

If you wish to discuss how you can get your life back without Morgellons, call our toll-free number and our experienced (5+ years working directly with Morgellons victims) counselors will help you through this nightmare.  We have seen thousands of Morgellons victims recover.  It is your turn now, so pick up your telephone and call this number now.

888-240-2326 Option #2

Morgellons Report by CDC, No Surprises Here; Morgellons Disease is Determined to be Delusional

Dr. Joe Shelby, MD

Although we have known the results of the long-awaited study by the CDC into Morgellons Disease, the Morgellons community at large is hugely disappointed by the results, published today. For well over a year, our insider, someone who was actually in the CDC study, shared the results with us.  According to our insider, Dr. Joe Shelby, the head of the Kaiser Permanente Hospital study into Morgellons disease in Oakland, California, told him that the study would conclude that Morgellons disease is delusional, all in the heads of Morgellons victims.

According to the Associate Press in Atlanta, Georgia;  “Imagine having the feeling that tiny bugs are crawling on your body, that you have oozing sores and mysterious fibers sprouting from your skin. Sound like a horror movie? Well, at one point several years ago, government doctors were getting up to 20 calls a day from people saying they had such symptoms.”

“Many of these people were in California and one of that state’s U.S. senators, Dianne Feinstein, asked for a scientific study. In 2008, federal health officials began to study people saying they were affected by this freakish condition called Morgellons.”

The study cost nearly $600,000. Its long-awaited results, released Wednesday, conclude that Morgellons exists only in the patients’ minds.

“We found no infectious cause,” said Mark Eberhard, a Centers for Disease Control and Prevention official who was part of the 15-member study team.

The study appears in PLoS One, one of the Public Library of Science journals and can be read in its entirety here.

Is this Morgellons baby delusional?

Is this baby delusional?

Imagine, a baby just born, coming from a water environment inside the womb, has lesions covering it’s body; is this baby delusional?

We have Morgellons sufferers all over the world

How can all of these people, who have never met or spoken with each other, share the same delusional?  I have personally videoed “critters” coming out of people’s bodies.  How can I video a delusion? None of this makes any sense at all. Yet, here are the results which took over 5 years to publish, that declares the thousands upon thousands of Morgellons sufferers delusional. Go figure….

If you have Morgellons disease, what can you do?

You can do what thousands of Morgellons sufferer around the world have done; you can call us. We have helped thousands of these unfortunate sufferers find their way out of this horrific infection. We can help you too.

Just pick up the phone and call us now.  In as little as 4 weeks, your symptoms can be gone.  Imagine, your brain fog goes away and you can think and reason again.  Imagine, you energy comes back and you can function again. Imagine you depression leaves and you can feel like yourself once again. Imagine, in about 4 weeks your lesions dry up and fall off, never to return.  Imagine that your Morgellons nightmare is over.  Call us now; you have suffered long enough.

888-240-2326 option #2

Dramatic Elimination of MRSA Using NutraSilver

Chris_H    Tampa, Florida June 2010

“This is our second order & we’re devoted customers for LIFE. I was extremely sick with my MRSA since 2005. Doctors just seemed to be killing me the more they treated me. I only had one so-called “good” week per month that I felt “OK.” We found NutraSilver mentioned on a MRSA discussion board, that day, on April 30th, we ordered. I need to tell you…I have not had one single down day since I’ve been taking NutraSilver. I no longer take 6 hour naps during the day (after a full nights rest), my rashes & boils disappeared entirely, sinus congestion & migraines no longer hit me (NOT even ONE since I started this), I no longer have any monster-sized gland swelling in my neck or bad ear infections (which I had 3 WEEKS out of each month)–and my energy is restored back to how it felt BEFORE I acquired MRSA in ’05. I am able to spend time doing things I love…most importantly, I am now able to spend A LOT of wake time with my teenage son! “

“I am a 38 year old female, single parent… I was terrified, hopeless & knew that I was inching closer to the grave, I prepared my Last Will & Testament and I put a couple Life Insurance policies on myself. I was very depressed from it all. I couldn’t help but be anything but with the thought of leaving my son behind.“

“Today…I sleep through the night, I am up early in the morning, no naps..I stay on the go, I am swimming 100 laps 6 days a week on top of my daily cardio & strength training. I haven’t had ANY energy to exercise since 2005!! I’m eating as a vegetarian now and since I ordered your product the first time around, I’ve lost 65 lbs that I had gained while I was down ill…with 20 more to go! “

 

19 Hospital visit and NutraSilver was the only thing that helped eliminate MRSA from my body

“NutraSilver has brought me back to LIFE. It’s literally wiped out ALL of my MRSA symptoms & I now keep it combined with a Pro-biotic and Golden Seal. I maintain taking NutraSilver at a dose 40 drops a day. My son and I cannot EVER thank you enough..YOU helped save my life when 19 hospital stays & the strongest of medication couldn’t even make a dent! “

“YOU GUYS ARE ANGELS!!! THANK YOU!!! THANK YOU!!!”

Call us for help!

We are here to help you eliminate your MRSA infection.  Please call our toll-free number for a free consultation on how this amazing natural mineral can help you.

888-240-2326 Option #2 pst